Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Internal Medicine (Tokyo, Japan)|August 14, 2018
The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell LymphomaAkira Tanimura, Risen Hirai, Miki Nakamura, et al.
American Journal of Hematology|October 10, 2012
YM-175 induces apoptosis of human native monocyte-lineage cells via inhibition of prenylationAkiyoshi Miwa, Naoki Takezako, Hiroko Hayakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 14, 2024
[Posterior reversible encephalopathy syndrome during nilotinib treatment for chronic myeloid leukemia]Daisuke Kudo, Hiroshi Suzuki, Naomi Abe, et al.
Internal Medicine (Tokyo, Japan)|November 2, 2011
Successful treatment of immunoglobulin D myeloma by bortezomib and dexamethasone therapyNaohiro Sekiguchi, Naoki Takezako, Akihisa Nagata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 30, 2003
[Myelodysplastic syndrome accompanied by Evans syndrome]Naoki Takezako, Tateki Shikai, Akira Tanimura, et al.
Thrombosis Research|May 3, 2015
Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapyNaoki Takezako, Naohiro Sekiguchi, Akihisa Nagata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 15, 2020
Efficacy of VRD(Bortezomib, Lenalidomide, and Dexamethasone) Consolidation Therapy and Maintenance Therapy with Immunomodulatory Drugs(Thalidomide or Lenalidomide) after Autologous Peripheral Blood Stem Cell Transplantation in the Era of Bortezomib-Containing Induction Therapy-A Single Institution ExperienceAkira Tanimura, Risen Hirai, Miki Nakamura, et al.
Leukemia & Lymphoma|June 9, 2011
Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot studyAkiyoshi Miwa, Naohiro Sekiguchi, Akira Tanimura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2010
[Altered gut bacterial flora and organic acids in feces of patients undergoing autologous stem cell transplantation with quinolone-based antibacterial prophylaxis]Shotaro Hagiwara, Shotaro Hagiwara, Takashi Asahara, et al.
Internal Medicine (Tokyo, Japan)|January 16, 2009
Autologous stem cell transplantation using MEAM regimen for relapsed AIDS-related lymphoma patients who received highly active anti-retroviral therapy: a report of three casesKimihito C Kawabata, Shotaro Hagiwara, Ayako Takenouchi, et al.
Pageof 4